Cumberland Pharmaceuticals Inc. rose 12.8% on Thursday, November 5, 2026, on 284,295 shares, 3.3 times its average daily volume. No headline about CPIX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ) closed at $5.01 on November 5, 2026, up 12.84% on the day. The stock trades 46.0% below its 52-week high of $9.28 and 170.8% above its 52-week low of $1.85. Over the past year, it gained 128.8%. Cumberland Pharmaceuticals Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 5, 2025, CPIX closed higher on 127 days (50%). Its best day was April 23, 2026 (+27.87%) and its worst was October 26, 2026 (-48.76%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 1 time.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for hospital acute care and gastroenterology markets in the United States and internationally. It marketed products include Acetadote (acetylcysteine) injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative; Vaprisol (conivaptan) injection for treating hyponatremia; Omeclamox-Pak for the treatment of H. pylori infection and duodenal ulcer disease; and Ethyol (amifostine) for injection to treat oncology patients. The company's product candidates in Phase II clinical trials comprise Hepatoren (ifetroban) injection for the treatment of hepatorenal syndrome; Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease; Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension. Its pre-approval products consist of Methotrexate injection for treating active rheumatoid, juvenile idiopathic, and psoriatic...
Find more stocks like CPIX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.